Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
PB

PBH

Market Closed

Prestige Consumer Healthcare Inc.

NYSEHealthcareMedical - Pharmaceuticals
US
890 employees
CEO: Ronald Lombardi
Founded: 2005
$49.46
+$0.00(+NaN%)
Market Cap
2.34B
Beta
0.34
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Prestige Consumer Healthcare’s current price ($49.46) is significantly below all valuation measures, indicating strong undervaluation with a high-confidence fair value median around $223.14. Monte Carlo analysis shows upside potential without downside risk below current price, despite high volatility (201% coefficient of variation). Financial health is good, marked by strong liquidity and leverage but moderate profitability and growth, suggesting stable fundamentals amid attractive valuation.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore PBH

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

PBH in the Healthcare

Mid Cap
Healthcare

Browse sector stocks →

Medical - Pharmaceuticals

Browse industry stocks →